Skip to content
Anavex Life Sciences Corp icon

Anavex Life Sciences Corp

AVXLStocksBiotechnologyUnited StatesNasdaqUSD

Price

Unknown

Today

-11.4%

YTD

-81.1%

About

Anavex is a healthcare business that develops drug candidates for the treatment of diseases of the central nervous system. Founded in 2004, the company has headquarters in New York City. Operating within the US, Anavex has been listed on the NASDAQ CM stock exchange under the ticker AVXL. Learn more about this instrument today and buy AVXL stock.

Price chart
Closing price history for AVXL (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-4.40
P/S (TTM)0.00
P/B (TTM)0.55
Market cap$61.88M
Cap tierMicro-cap
Industry avg P/E-5.49

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-12.80%
ROA-11.70%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$0.15
Free cash flow$-29.29M
Total debt$0.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.70
Employees34
Next earnings24 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Anavex Life Sciences Corp (AVXL) | Dirk Kuyken